A major problem in amyloid-p peptide (A(3) related research is the inconsistency introduced by the multiple and varied protocols employed by different laboratories for isolating, analyzing, quantifying, preparing and handling Af3;the centralization of procedures within this Core will circumvent these inconsistencies. This Core thus has two specific aims: to provide an A(3 index to each project, and to supply A(3 to each project. Ap index: Different aspects of Ap (concentration, physiological properties, deposition, etc.) are often measured in isolation. To date, a comprehensive assessment of these aspects has not been performed in the same tissue. For each project, Core B will collect and collate, from both human and rodent tissues, the following data: (a) the amounts of Ap (including AP40 and A042) and its solubility, (b) the amounts of oligomeric and fibrillar Ap, and (c) the number of neuritic and non-neuritic plaques. These data will allow the determination of the relationship(s) between individual changes in Ap and the various neurochemical end point measures studied in the different projects. Supply Ap: Evaluation of the physiological properties and toxicity of Ap has been hampered by inconsistencies caused by variability in every possible aspect of Ap handling. Core B will maintain consistency between projects by controlling each of these different variables (peptide acquisition and storage, preparation and quantification of oligomers and fibrils, quantification of toxicity) through adherence to established, standardized protocols and through maintenance of rigid quality control. The novelty of this Core is its thoroughness. We have assembled a unique group of investigators who, together, possess proven expertise for each function of Core B. Utilizing methods that are well characterized and established in their respective laboratories, this team-oriented approach will allow the first comprehensive, multifaceted analysis of Ap in vivo and in vitro. Ultimately, this will provide an unprecedented level of thoroughness and rigor to Ap analysis, imparting much needed fidelity and continuity to project data. First and foremost, the data and materials generated in Core B will allow the individual projects to correlate each of their individual neurochemical alterations to different aspects of Ap assembly, deposition and toxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG005119-21
Application #
7805525
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2009-04-15
Budget End
2010-03-31
Support Year
21
Fiscal Year
2009
Total Cost
$303,585
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Ding, Qunxing; Zhu, Haiyan (2018) Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies. Neurosci Lett 678:131-137
Ellison, Elizabeth M; Abner, Erin L; Lovell, Mark A (2017) Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease. J Neurochem 140:383-394
Hartz, Anika M S; Zhong, Yu; Wolf, Andrea et al. (2016) A?40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. J Neurosci 36:1930-41
Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra (2016) Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics 13:259-74
Chen, Chun-Hau; Li, Wenzong; Sultana, Rukhsana et al. (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis 76:13-23
Lovell, Mark A; Abner, Erin; Kryscio, Richard et al. (2015) Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxid Med Cell Longev 2015:787805
Sethi, M; Joshi, S S; Webb, R L et al. (2015) Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's disease. Neuroscience 290:80-9
Bradley-Whitman, Melissa A; Lovell, Mark A (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Arch Toxicol 89:1035-44
Barone, Eugenio; Cenini, Giovanna; Di Domenico, Fabio et al. (2015) Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53. J Neurosci Res 93:1728-39
Di Domenico, Fabio; Pupo, Gilda; Mancuso, Cesare et al. (2015) Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease. J Alzheimers Dis 44:1107-20

Showing the most recent 10 out of 244 publications